Oncologist and researcher on Myeloma service @sloan_kettering. Interested in nutrition for cancer and immune therapies. Views are my own
Dec 29, 2023 • 5 tweets • 2 min read
1/5 @HundalJasmin and I summarize the results of the DIANA-5 trial (randomized trial of a macro-Mediterranean diet for breast cancer recurrence) in context @practiceupdate #bcsm @MSKCancerCenter @MSK_DeptOfMed @aicrtweets @ACLifeMed @Neil_Iyengar @Rfonsi1 practiceupdate.com/content/the-ef…2/5 This study highlights the challenges in conducting large long term behavioral lifestyle interventions. The results showed no significant difference in breast cancer recurrence rates between the intervention and control groups (HR, 0.99; 95% CI, 0.69–1.14). #bcsm
With #ASH20 around the corner, I wanted to share a summary of the major myeloma immunotherapy - CARs, Bispecifics, ADCs trials and #ASH20 abstracts to look out for #mmsm from a recent talk I gave bmj.com/content/370/bm…
I will focus on some of the major drugs in this thread (in the blue boxes). Although I may not be able to cover all of them, the trials I have typed over the image are the ones to watch out for at #ASH20